G-619

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameG-619
Drug Alias NameG-619
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitorsPlatelet aggregation inhibitorsProstanoid receptor antagonists
TargetsThromboxane A2 synthaseProstanoid receptor
Therapy Area/IndicationsPeripheral Vascular DiseasesMyocardial IschemiaStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc +[2] 
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesMyocardial IschemiaStroke

Other Information

ATC CodeN/A
Related LinksN/A